- Active ingredient:
- Each film-coated tablet contains 0.532 mg of entecavir monohydrate, equivalent to 0.5 mg of entecavir.
- Pharmaceutical form:
- Film-coated tablet: A white, round film-coated tablet.
- Route of administration:
- HEPAGARD is taken orally. In nucleoside-naive patients, the recommended dose is 0.5 mg once daily, either on a full stomach or on an empty stomach. HEPAGARD should be taken on an empty stomach (approximately 2 hours before or 2 hours after a meal) in patients with lamivudine-resistant HBV or decompensated liver disease.